Össur hf: Interim Report Q3 2022
Announcement no. 61/2022 Interim Report Q3 2022 25 October 2022 Sveinn Sölvason, President and CEO, Comments: “Sales amounted to 177 million and EBITDA margin before special items was 20% in Q3 2022. Growth was very strong in APAC as both China and Australia are regaining ground and sales were stronger in Americas this quarter. We continue to face supply chain challenges and emphasize delivering our products and solutions to patients. Interest in the Power Knee remains high, and patient and provider satisfaction fuels our ongoing dedication to improving people’s mobility. We